112 related articles for article (PubMed ID: 2822584)
1. The role of chromosome 15 in murine leukemogenesis. II. Relationship between tumorigenicity and the dosage of lymphoma vs. normal-parent-derived chromosomes 15 in somatic cell hybrids.
Uno M; Wirschubsky Z; Babonits M; Wiener F; Sümegi J; Klein G
Int J Cancer; 1987 Oct; 40(4):540-9. PubMed ID: 2822584
[TBL] [Abstract][Full Text] [Related]
2. Relationship between tumorigenicity and the dosage of lymphoma- vs. normal-parent-derived chromosome 15 in somatic cell hybrids between lymphoma cells with rearranged pvt-1 gene and normal cells.
Uno M; Wirschubsky Z; Wiener F; Klein G
Int J Cancer; 1989 Aug; 44(2):353-9. PubMed ID: 2788146
[TBL] [Abstract][Full Text] [Related]
3. The role of chromosome 15 in murine leukemogenesis. I. Contrasting behavior of the tumor vs. normal parent-derived chromosomes No. 15 in somatic hybrids of varying tumorigenicity.
Spira J; Wiener F; Babonits M; Gamble J; Miller J; Klein G
Int J Cancer; 1981 Dec; 28(6):785-98. PubMed ID: 7333707
[TBL] [Abstract][Full Text] [Related]
4. Suppression of tumorigenicity in T-cell lymphoma hybrids is correlated with changes in myc expression and DNA replication of the myc chromosomal domain.
Eul J; Gronemeyer H; Adolph S; Hameister H
Chromosoma; 1988; 96(3):248-54. PubMed ID: 3258808
[TBL] [Abstract][Full Text] [Related]
5. Triplication of one chromosome No. 15 with an altered c-myc containing EcoRI fragment and elimination of the normal homologue in a T-cell lymphoma line of AKR origin (TIKAUT).
Wirschubsky Z; Wiener F; Spira J; Sümegi J; Klein G
Int J Cancer; 1984 Apr; 33(4):477-81. PubMed ID: 6323325
[TBL] [Abstract][Full Text] [Related]
6. Inheritance of immunogenicity and metastatic potential in murine cell hybrids from the T-lymphoma ESb08 and normal spleen lymphocytes.
Larizza L; Schirrmacher V; Stöhr M; Pflüger E; Dzarlieva R
J Natl Cancer Inst; 1984 Jun; 72(6):1371-81. PubMed ID: 6610070
[TBL] [Abstract][Full Text] [Related]
7. Hypersomy of chromosome 15 with retrovirally rearranged c-myc, loss of germline c-myc and IgK/c-myc juxtaposition in a macrophage-monocytic tumour line.
Imreh S; Wang Y; Panda CK; Babonits M; Axelson H; Silva S; Szeles A; Wiener F; Klein G
Eur J Cancer; 1994; 30A(7):994-1002. PubMed ID: 7946599
[TBL] [Abstract][Full Text] [Related]
8. Tumorigenicity of human HT1080 fibrosarcoma X normal fibroblast hybrids: chromosome dosage dependency.
Benedict WF; Weissman BE; Mark C; Stanbridge EJ
Cancer Res; 1984 Aug; 44(8):3471-9. PubMed ID: 6744274
[TBL] [Abstract][Full Text] [Related]
9. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss.
Jox A; Taquia E; Vockerodt M; Draube A; Pawlita M; Möller P; Bullerdiek J; Diehl V; Wolf J
Cancer Res; 1998 Nov; 58(21):4930-9. PubMed ID: 9810002
[TBL] [Abstract][Full Text] [Related]
10. Suppression of tumorigenicity in somatic cell hybrids. III. Cosegregation of human chromosome 11 of a normal cell and suppression of tumorigenicity in intraspecies hybrids of normal diploid x malignant cells.
Kaelbling M; Klinger HP
Cytogenet Cell Genet; 1986; 41(2):65-70. PubMed ID: 3956263
[TBL] [Abstract][Full Text] [Related]
11. Modification of myc gene amplification in human somatic cell hybrids.
Iman DS; Shay JW
Cancer Res; 1989 Aug; 49(16):4417-22. PubMed ID: 2568170
[TBL] [Abstract][Full Text] [Related]
12. Analysis of oncogene, tumor suppressor gene, and chromosomal alterations in HeLa x osteosarcoma somatic cell hybrids.
Isfort RJ; Cody DB; Lovell GJ; Gioeli D; Weissman BE; Doersen CJ
Mol Carcinog; 1999 May; 25(1):30-41. PubMed ID: 10331742
[TBL] [Abstract][Full Text] [Related]
13. Rearrangement of c-myc, pim-1 and Mlvi-1 and trisomy of chromosome 15 in MCF- and Moloney-MuLV-induced murine T-cell leukemias.
Wirschubsky Z; Tsichlis P; Klein G; Sumegi J
Int J Cancer; 1986 Nov; 38(5):739-45. PubMed ID: 3021636
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional down-regulation of the rearranged C-myc expression in murine cell hybrids between a plasmacytoma and a T-cell lymphoma.
Oikawa T; Kondoh N; Fujita H; Satoh C; Li SZ; Yoshida MC; Imamura M; Onoé K; Kuzumaki N
Int J Cancer; 1990 Mar; 45(3):468-74. PubMed ID: 2307537
[TBL] [Abstract][Full Text] [Related]
15. Suppression of tumorigenicity in somatic cell hybrids. II. Human chromosomes implicated as suppressors of tumorigenicity in hybrids with Chinese hamster ovary cells.
Klinger HP; Shows TB
J Natl Cancer Inst; 1983 Sep; 71(3):559-69. PubMed ID: 6577230
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of the normal and of the translocated human c-myc oncogenes in B cells.
Nishikura K; ar-Rushdi A; Erikson J; Watt R; Rovera G; Croce CM
Proc Natl Acad Sci U S A; 1983 Aug; 80(15):4822-6. PubMed ID: 6308654
[TBL] [Abstract][Full Text] [Related]
17. Tumorigenicity of T lymphoma/T lymphoma hybrids and T lymphoma/normal cell hybrids.
Hays EF; Weinroth SE; MacLeod CL; Kitada S
Int J Cancer; 1986 Oct; 38(4):597-601. PubMed ID: 3759264
[TBL] [Abstract][Full Text] [Related]
18. Correlation of myc expression with the growth-arrested and transformed phenotypes in hybrids between a T lymphoma and an antigen-responsive T-cell line.
Kubota K; Imreh S; Katoh H; Babonits M; Wiener F
Int J Cancer; 1992 Jul; 51(6):927-34. PubMed ID: 1639541
[TBL] [Abstract][Full Text] [Related]
19. Role of chromosome loss in ras/myc-induced Syrian hamster tumors.
Oshimura M; Koi M; Ozawa N; Sugawara O; Lamb PW; Barrett JC
Cancer Res; 1988 Mar; 48(6):1623-32. PubMed ID: 2449958
[TBL] [Abstract][Full Text] [Related]
20. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression.
Wolf J; Pawlita M; Bullerdiek J; zur Hausen H
Cancer Res; 1990 May; 50(10):3095-100. PubMed ID: 2159373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
